A61K 39/002
Protozoa antigens
A61K39/002 (Protozoa antigens) appears on 801 US grants and 1,117 published applications in this corpus.
Search patents in A61K- Granted patents
- 801
- Published applications
- 1,117
- Assignees
- 625
- Inventors
- 2,094
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 1 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 2 | 0 |
| 1982 | 2 | 0 |
| 1983 | 0 | 0 |
| 1984 | 6 | 0 |
| 1985 | 2 | 0 |
| 1986 | 3 | 0 |
| 1987 | 2 | 0 |
| 1988 | 7 | 0 |
| 1989 | 5 | 0 |
| 1990 | 2 | 0 |
| 1991 | 5 | 0 |
| 1992 | 1 | 0 |
| 1993 | 2 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 6 | 0 |
| 1997 | 6 | 0 |
| 1998 | 12 | 0 |
| 1999 | 13 | 0 |
| 2000 | 12 | 0 |
| 2001 | 11 | 1 |
| 2002 | 10 | 31 |
| 2003 | 11 | 32 |
| 2004 | 10 | 30 |
| 2005 | 14 | 37 |
| 2006 | 16 | 41 |
| 2007 | 25 | 25 |
| 2008 | 22 | 46 |
| 2009 | 18 | 41 |
| 2010 | 22 | 60 |
| 2011 | 19 | 53 |
| 2012 | 29 | 51 |
| 2013 | 31 | 53 |
| 2014 | 37 | 48 |
| 2015 | 42 | 51 |
| 2016 | 40 | 53 |
| 2017 | 50 | 60 |
| 2018 | 46 | 56 |
| 2019 | 43 | 50 |
| 2020 | 37 | 53 |
| 2021 | 43 | 58 |
| 2022 | 33 | 47 |
| 2023 | 25 | 37 |
| 2024 | 30 | 43 |
| 2025 | 31 | 32 |
| 2026 | 14 | 28 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Probiotic Bacillus compositions and methods of use29 Sep 2026US 12,746,261 B2BiomEdit, Inc.
- Chagas disease vaccine antigens with improved stability and decreased aggregation29 Sep 2026US 12,746,280 B2Baylor College of Medicine
- Live attenuated Leishmania parasite vaccines with enhanced safety characteristics16 Jun 2026US 12,653,875 B2Ohio State Innovation Foundation
- Anti-parasitic immunological compositions9 Jun 2026US 12,648,993 B2Board of Regents of the University of Nebraska
- Transmission-blocking vaccine against Babesia26 May 2026US 12,636,355 B2James Cook University
- Inhaled adenovirus vector vaccine, preparation method therefor and use thereof8 Oct 2026US 2026/0306605 A1Cansino Biologics Inc.
- Liposomal formulation for treatment of visceral leishmaniasis24 Sep 2026US 2026/0284167 A1Council of Scientific and Industrial Research
- Live attenuated leishmania parasite vaccines with enhanced safety characteristics17 Sep 2026US 2026/0273036 A1Ohio State Innovation Foundation
- Modified virus-like particles of cmv10 Sep 2026US 2026/0263612 A1Saiba GmbH
- Eimeria vaccine10 Sep 2026US 2026/0265684 A1Eimeria Pty. Limited
Most cited
By later US patents
- Submicron emulsions as vaccine adjuvants129US 5,961,970 APharmos Corporation · 1999
- Hybrid particle immunogens118US 4,722,840 AChiron Corporation · 1988
- Zika virus RNA vaccines108US 10,124,055 B2ModernaTX, Inc. · 2018
- Vaccines102US 6,544,518 B1SmithKline Beecham Biologicals s.a. · 2003
- Adjuvant systems and vaccines92US 7,357,936 B1SmithKline Beecham Biologicals s.a. · 2008